title: [Aerosol-pentamidine for pneumocystis carinii pneumonia: development and 4-year personal experiences].
authors.affiliation: Infectious Diseases Service, Memorial Sloan-Kettering Cancer Center, New York.
authors.forename: H J
authors.initials: HJ
authors.lastname: Schmitt
authors.forename: D
authors.initials: D
authors.lastname: Armstrong
authors.forename: E
authors.initials: E
authors.lastname: Bernard
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D000336:Aerosols; D000368:Aged; D000818:Animals; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010419:Pentamidine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000517:prevention & control*; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D000336:Aerosols; D010419:Pentamidine
vernacular_title: Aerosol-Pentamidin (AP) gegen die Pneumocystis carinii Pneumonie (PCP): Entwicklung und eigene Erfahrungen über 4 Jahre.